Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04497441
Other study ID # QassimU3
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 10, 2020
Est. completion date August 15, 2020

Study information

Verified date August 2020
Source Qassim University
Contact Bugude Shiva Shankar, MDS
Phone +966163020523
Email S.ggg@qu.edu.sa
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

COVID-19 Infection was characterized as a Pandemic by WHO on the 11th of March 2020.1 After this there were all possible worldwide efforts to increase awareness in the general population about the COVID-19 Infection signs, symptoms, mode of transmission and prevention. The information was spread across all possible mass media communication channels. There were constant updates regarding the data of newly infected cases, deaths, and recoveries. This cross sectional study is conducted with the following objectives:

1. To understand the netizens perception regarding the sources of information available on COVID-19.

2. To understand the netizens populations perception regarding the available information on COVID-19.


Description:

Mass media plays a significant role in public outreach and create awareness. Various mass media has their individual reach to the general public. In the current world of information technology availability of information is not an issue. There is in fact excessive availability of information. What makes a big difference is that RIGHT information delivery on RIGHT time and within RIGHT time. After WHO characterized COVID-19 infection as pandemic, mass media played a significant role in creating awareness regarding COVID-19 infection signs, symptoms, mode of transmission and its prevention. There were constant updates in various mass media regarding the data of newly infected cases, deaths, and recoveries. COVID-19 Pandemic has created fears, anxiety, and worries among the general population. There was information given to general public regarding treatment drugs and possibility of vaccine for COVID-19 infection. This created a ray of hope in many. So information in various mass media sources had different types of impact on general population thoughts.

This cross sectional study is conducted with the following objectives:

1. To understand the general populations perception regarding the sources of information available on COVID-19.

2. To understand the general populations perception regarding the available information on COVID-19.

This Cross sectional study utilizes an electronic google form to get responses from netizens of Al Qassim province of Saudi Arabia regarding the perception of COVID-19 information and information sources. All the questions in the survey are compulsory answerable questions. The settings in the google form are set so that a single respondent can limit the survey response to single time. The Survey Questionnaire contained following sections:

Section I: Minimum required personal details Section II: 10 Questions regarding the source of COVID-19 information Section III: 6 Questions regarding perception of the COVID-19 information

The questionnaire also carried the following disclaimer:

"This Survey will not Collect your Name, Email, Location, and Phone number. We pledge that the data obtained by this survey is for Educational purpose & scientific knowledge enhancement only. The data will not be transferred or shared with any other third party for commercial interest."

The very first part of the Questionnaires seeks responders' consent for giving responses to the survey questions. participation Section II & III contained all closed ended questions. The Google form link is shared to the netizens of Al Qassim province across relevant Social media platforms.


Recruitment information / eligibility

Status Recruiting
Enrollment 385
Est. completion date August 15, 2020
Est. primary completion date August 10, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria:

- Male and Female Human volunteer internet users who belong &/or reside in Al Qassim province region of Saudi Arabia.

- Volunteers should be major by age (18 years and above).

Exclusion Criteria:

- Minor age group (<18 years) subjects are excluded from the study.

- Internet users who have preexisting phobia and/or anxiety mental conditions are excluded from the study.

- Internet users who are currently under treatment for their preexisting phobia and/or anxiety mental conditions are excluded from the study.

Study Design


Intervention

Other:
Electronic Survey questionnaire
This Cross sectional study utilizes an electronic google form to get responses from netizens of Al Qassim province of Saudi Arabia regarding the perception of COVID-19 information and information sources. All the questions in the survey are compulsory answerable questions. The settings in the google form are set so that a single respondent can limit the survey response to single time. The Survey Questionnaire contained following sections: Section I: Minimum required personal details Section II: 10 Questions regarding the source of COVID-19 information Section III: 6 Questions regarding perception of the COVID-19 information The very first part of the Questionnaires seeks responders' consent for giving responses to the survey questions. participation Section II & III contained all closed ended questions. The Google form link is shared to the netizens of Al Qassim province across relevant Social media platforms.

Locations

Country Name City State
Saudi Arabia Dr Bugude Shiva Shankar Ar Rass Al Qassim

Sponsors (1)

Lead Sponsor Collaborator
Qassim University

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Netizens' perception of the Sources of COVID-19 information Assessing the perception regarding the Sources of COVID-19 information among netizens in Al Qassim province using a 10 open ended Questionnaire. Descriptive statistics will be used to present the data. 11th of August 2020
Primary Netizens' perception on COVID-19 information Assessing the perception regarding COVID-19 information among netizens in Al Qassim province using a 6 open ended Questionnaire. Descriptive statistics will be used to present the data. 11th of August 2020
Secondary Correlation of Age and the Frequency of checking COVID-19 information updates The survey data will be statistically analyzed to check for the Correlation of Age and the Frequency of checking COVID-19 information updates. The data obtained from the survey will be subjected to appropriate analytical statistical tests to understand the correlation. A p-value of <0.05 is considered statistically significant correlation of the variables analysed. 11th of August 2020
Secondary Correlation of Gender and the Frequency of checking COVID-19 information updates The survey data will be statistically analyzed to check for the Correlation of Gender and the Frequency of checking COVID-19 information updates. The data obtained from the survey will be subjected to appropriate analytical statistical tests to understand the correlation. A p-value of <0.05 is considered statistically significant correlation of the variables analysed. 11th of August 2020
Secondary Correlation of Age and the perception of newly infected COVID-19 cases information update The survey data will be statistically analyzed to check for the Correlation of Age and the perception of newly infected COVID-19 cases information update. The data obtained from the survey will be subjected to appropriate analytical statistical tests to understand the correlation. A p-value of <0.05 is considered statistically significant correlation of the variables analysed. 11th of August 2020
Secondary Correlation of Age and the perception of COVID-19 deaths information update The survey data will be statistically analyzed to check for the Correlation of Age and the perception of COVID-19 deaths information update. The data obtained from the survey will be subjected to appropriate analytical statistical tests to understand the correlation. A p-value of <0.05 is considered statistically significant correlation of the variables analysed. 11th of August 2020
Secondary Correlation of Age and the perception of COVID-19 Vaccine information update The survey data will be statistically analyzed to check for the Correlation of Age and the perception of COVID-19 Vaccine information update. The data obtained from the survey will be subjected to appropriate analytical statistical tests to understand the correlation. A p-value of <0.05 is considered statistically significant correlation of the variables analysed. 11th of August 2020
Secondary Correlation of Age and the perception of COVID-19 treatment medicines/drugs information update The survey data will be statistically analyzed to check for the Correlation of Age and the perception of COVID-19 treatment medicines/drugs information update. The data obtained from the survey will be subjected to appropriate analytical statistical tests to understand the correlation. A p-value of <0.05 is considered statistically significant correlation of the variables analysed. 11th of August 2020
See also
  Status Clinical Trial Phase
Completed NCT05047692 - Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers Phase 1
Recruiting NCT04395768 - International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 Phase 2
Completed NCT04506268 - COVID-19 SAFE Enrollment N/A
Terminated NCT04555096 - A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Phase 2
Completed NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure
Completed NCT04961541 - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Phase 1/Phase 2
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Terminated NCT04581915 - PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 Phase 2/Phase 3
Not yet recruiting NCT04543006 - Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19 N/A
Terminated NCT04542993 - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy Phase 2
Completed NCT04532294 - Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants Phase 1
Completed NCT04494646 - BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Phase 2
Completed NCT04387292 - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic N/A
Not yet recruiting NCT04527211 - Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel Phase 3
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Not yet recruiting NCT05038449 - Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 N/A
Completed NCT04979858 - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask N/A
Completed NCT04610502 - Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Phase 2
Active, not recruiting NCT06042855 - ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) Phase 3